Organisation paid for research Program year 2023 Source: CMS Open Payments

The Cooper Health System

Neither a doctor nor a teaching hospital

Research payments

$154,658

76 payments

Through program year 2023, The Cooper Health System is reported as receiving $154,658 in research payments, across 76 payments.

By program year

5 rows

Year	Kind	Amount	Payments
2023	Research	$14,018	5
2022	Research	$20,163	5
2021	Research	$41,283	9
2020	Research	$43,641	28
2019	Research	$35,553	29

Breakdown

Who paid Research payments · program years 2019–2023

ViiV Healthcare Company $80,867 26 payments
Daiichi Sankyo Inc. $37,954 29 payments
EMD Serono, Inc. $13,938 15 payments
AMAG Pharmaceuticals, Inc. $11,900 5 payments
Endomagnetics Ltd $10,000 1 payment

Studies the money was for Research payments · program years 2019–2023

PH 3 HIV Two-Year Non-Inferiority Compared to Standard of Care Safety/ $68,367 19 payments
Plx108-10 $25,299 28 payments
A Phase I, open-label, multiple-ascending dose trial to investigate the safety, tolerability, pharmacokinetics, biological ad clinical activity of MSB0010718C in subjects with metastatic or locally advanced solid tumors and expansion to selected indications. $13,938 15 payments
Plx108-10 $12,655 1 payment
A Phase Iib, Randomized, Partially Blind, Active Controlled, Dose-Rang $12,500 7 payments
A Phase 2b3a, Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study of the Efficacy and Safety of AMAG-423, a Digoxin Immune Fab, in Antepartum Subjects With Severe Preeclampsia $11,900 5 payments
Magellan $10,000 1 payment

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.